ArticleOncotarget2015

Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy.

Cristina Talarico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.